BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

Search

Fisher & Paykel Healthcare Corp Ltd

Fechado

SetorImobiliário

33.77 0.12

Visão Geral

Variação de preço das ações

24h

Atual

Mín

33.5

Máximo

33.9

Indicadores-chave

By Trading Economics

Rendimento

224M

377M

Vendas

329M

1.3B

P/E

Médio do Setor

56.712

58.706

EPS

0.26

Rendimento de Dividendos

1.15

Margem de lucro

29.462

Funcionários

7,384

EBITDA

379M

654M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+13.45% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.15%

5.81%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-1.4B

20B

Abertura anterior

33.65

Fecho anterior

33.77

Fisher & Paykel Healthcare Corp Ltd Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

28 de mai. de 2025, 22:28 UTC

Conversa de Mercado

Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

8 de abr. de 2025, 02:01 UTC

Conversa de Mercado

Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk

3 de fev. de 2025, 21:55 UTC

Conversa de Mercado

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 de fev. de 2025, 22:06 UTC

Conversa de Mercado

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 de nov. de 2024, 21:55 UTC

Conversa de Mercado

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 de nov. de 2024, 22:39 UTC

Conversa de Mercado

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2 de set. de 2024, 23:56 UTC

Conversa de Mercado

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

Comparação entre Pares

Variação de preço

Fisher & Paykel Healthcare Corp Ltd Previsão

Preço-alvo

By TipRanks

13.45% parte superior

Previsão para 12 meses

Média 38.347 AUD  13.45%

Máximo 42.1 AUD

Mínimo 35.9 AUD

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para Fisher & Paykel Healthcare Corp Ltd - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

9 ratings

5

Comprar

4

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.